Anticoagulant Reversal Drugs Market Size, Share & Growth Analysis By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), And Regional Forecast, 2021-2027

Category:Pharmaceuticals & Healthcare
Published on:Nov 2021
Pages:150
Formats:
Report Code:40701

Request PDF Sample Ask for Customization Inquire Before Buying

Report Overview

Report Summary

The Global Anticoagulant Reversal Drugs Market Size, Share & Growth Analysis By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), And Regional Forecast, 2021-2027, This research & consulting report doles out information about the global Anticoagulant Reversal Drugs market. The forecast period of the market extends till 2027, while commencing in 2020. The report sheds light on various key insights & trends that have occupied center stage & drawn the attention of end-users. The Anticoagulant Reversal Drugs industry is witnessing impressive expansion at present, having logged double digit CAGRs in the past.

The Global Anticoagulant Reversal Drugs Market size was valued at USD 689.84 million in 2020 and is expected to expand at a CAGR of 14.9% from 2021 to 2027.

The report alludes to the Anticoagulant Reversal Drugs market as a lucrative sector. This sector is slated to generate substantial revenues during forecast period 2021 to 2027. The analytical report highlights data & overview regarding the size, shares, & demand of Anticoagulant Reversal Drugs. Several other factors have had a positive or negative impact on the industry, all of which have been laid out in details.

Pros & Scope of The Report

The said factors comprise drivers, novel prospects, hindrances, and other vital characteristics of the market. Investments by rivals into Anticoagulant Reversal Drugs products have catapulted the market into limelight & have stoked its demand, globally.

Few among other key aspects that find a mention; encompass the industry segments, predictions, & size and shares for 2021 to 2027. Besides these; the report narrows down on the innovative trends & technological developments, expansion strategies of key players, and regional statistics.

Some Of The Companies For Anticoagulant Reversal Drugs Market Are:

More Inputs & Objectives

The manner in which nascent & local competitors stack up against prominent players, hogs the spotlight. Novel products & services, coupled with the monetary shares of eminent competitors and the SWOT analysis unveil the complexities of the global industry size.

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2021 to 2027 in each of the sub segments. For the purpose of this study, Eternity Insights has segmented the global Anticoagulant Reversal Drugs market on the basis of product type, distribution channel and region:

Anticoagulant Reversal Drugs Market, By Product Type

Anticoagulant Reversal Drugs Market, By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Anticoagulant Reversal Drugs Market, By Regional Outlook

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- BENELUX
- Italy
- Spain
- Switzerland
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of APAC
Latin America
- Brazil
- Rest of LATAM
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA

Research Methodology

Research methodology is an integral component of any kind of high-level market research. It entails evaluation by expert panels, research on secondary & primary levels, checks on quality, & testing on completion. Secondary research deeply focuses on the whys, whos, wheres, whens, & hows and caters to answering the strictly consumer-centric base of people.

Some other secondary research sources comprise governmental affiliations & blogs, business magazines, and industrial journals. Primary research includes face-to-face & telephonic interviews with industry experts. It is comparatively more detailed & lays stress on unprejudiced opinions about the products & services.

Primary research findings cement secondary research & help end-users & businesses get a better hang of various markets. It is a well-established fact, though, that research methodology is best implemented through the mixed execution of its aforementioned procedures.

What Does the Report Offer?

A break down & profiling of the qualitative & quantitative analysis of the industry.
An in-depth overview of the segments & sub-segments of the industry, unlocking their shares and positions.
Data on market players & their growth strategies.
Industry outlook, via value chains.
Mergers & acquisitions, the SWOT analysis of prominent competitors, and high-tech product launches.
Drivers, hindrances, factors that positively & negatively impact the market, and new opportunities.
Crucial information and actionable insights, enabling businesses to widen their traction & to have an edge over others.
Regions into which the global market is fragmented and the reigning regional markets & their respective shares & revenues.
Analytical support on the purchases made/orders passed.

Other Vital Points That Are Covered

The impact of Covid-19 on each of the segments of the Anticoagulant Reversal Drugs market.

The suppliers, manufacturers, raw materials, dominating players, etc.

Key regional contributors & their shares in the past and the future.

Evaluation of most of the important countries within particular regions in view of their revenues, supplies, supremacy, business returns, & consumption volumes.

Advanced technologies that surround the market and comprehensive outlook on industry applications, products, end-users, & regions.

Technological & statistical data to cater to the demands of businesses, shareholders, & companies and to help them grow further.

Comparison of competitors against other players and the dominant companies during the forecast period. Strategies employed by reigning stakeholders to gain further traction & to generate higher revenues.

End users that are ahead in the rat race and the positive factors that influence those end users.

Applications that should come out on top by the end of the forecast period.

Products that occupy the maximum shares and the drivers behind those products.

Factors that bode well for the Anticoagulant Reversal Drugs market and a mention of other industries that are closely associated with the Anticoagulant Reversal Drugs market.

Regions that open the floodgates to higher investments and greater opportunities.

Records of the market sales, volumes, CAGRs, & shares.

The market report also brings to light major opportunities and untapped geographies. It is more like a blend of customized research documents & conventional reports. Besides informing buyers about the pros & cons of direct and indirect sales channels, the analysis exhibits illustrations & graphical representations of industry growth and the innovative trends within the industry.

Table Of Contents

Table of Contents

Chapter 1 Methodology and Scope

1.1 Market segmentation & scope

1.2 Market definition

1.3 Information procurement

1.3.1 Purchased database

1.3.2 Eternity Insights internal database

1.3.3 Secondary sources & third party perspectives

1.3.4 Primary research

1.4 Information analysis

1.4.1 Data analysis models

1.5 Market formulation & data visualization

1.6 Data validation & publishing

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

Chapter 3 Anticoagulant Reversal Drugs Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Ancillary Market Outlook

3.2 Penetration and Growth Prospect Mapping

3.3 Market Dynamics

3.3.1 Market driver analysis

3.3.1.1 Approval and launch of novel drugs

3.3.1.2 Increasing prevalence of bleeding disorders

3.3.1.3 Rise in incidence of indications for anticoagulant therapy

3.3.2 Market Restraint Analysis

3.3.2.1 High cost of reversal therapies

3.3.3 Industry challenges

3.4 Anticoagulant Reversal Drugs Market Analysis Tools

3.4.1 Industry analysis - Porter’s

3.4.1.1 Supplier Power

3.4.1.2 Buyer Power

3.4.1.3 Substitution Threat

3.4.1.4 Threat from new entrants

3.4.1.5 Competitive Rivalry

3.4.2 PESTEL Analysis

3.4.2.1 Political Landscape

3.4.2.2 Environmental Landscape

3.4.2.3 Social landscape

3.4.2.4 Application landscape

3.4.2.5 Legal Landscape

Chapter 4 Anticoagulant Reversal Drugs Market - Competitive Analysis

4.1 Recent Developments & Impact Analysis, by Key Market Participants

4.2 Vendor Landscape

4.2.1 List of key distributors and channel partners

4.2.2 Key company market share analysis, 2020

4.3 Public Companies

4.3.1 Company market position analysis

4.3.2 Competitive dashboard analysis

4.4 Private Companies

4.4.1 List of key emerging companies

4.4.2 Regional network map

4.4.3 Company market position analysis

Chapter 5 Anticoagulant Reversal Drugs Market: Product Type Estimates And Trend Analysis

5.1 Definition & Scope

5.2 Product Type Market Share Analysis, 2020 & 2027

5.3 Segment Dashboard

5.4 Global Anticoagulant Reversal Drugs Market, by Product Type, 2017 to 2027

5.5 Market Size & Forecasts and Trend Analyses, 2017 to 2027

5.5.1 Prothrombin Complex Concentrates

5.5.1.1 Prothrombin Complex Concentrates Market Estimates and Forecasts, 2017 to 2027 (USD Million)

5.5.2 Phytonadione

5.5.2.1 Phytonadione Market Estimates and Forecasts, 2017 to 2027 (USD Million)

5.5.3 Andexanet Alfa

5.5.3.1 Andexanet Alfa Market Estimates and Forecasts, 2017 to 2027 (USD Million)

5.5.4 Idarucizumab

5.5.4.1 Idarucizumab Market Estimates and Forecasts, 2017 to 2027 (USD Million)

5.5.5 Protamine

5.5.5.1 Protamine Market Estimates and Forecasts, 2017 to 2027 (USD Million)

5.5.6 Others

5.5.6.1 Others Market Estimates and Forecasts, 2017 to 2027 (USD Million)

Chapter 6 Anticoagulant Reversal Drugs Market: Distribution Channel Estimates And Trend Analysis

6.1 Definition & Scope

6.2 Distribution Channel Market Share Analysis, 2020 & 2027

6.3 Segment Dashboard

6.4 Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2017 to 2027

6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2027

6.5.1 Hospital Pharmacy

6.5.1.1 Hospital Pharmacy Market Estimates and Forecasts, 2017 to 2027 (USD Million)

6.5.2 Retail Pharmacy

6.5.2.1 Retail Pharmacy Market Estimates and Forecasts, 2017 to 2027 (USD Million)

6.5.3 Online Pharmacy

6.5.3.1 Online Pharmacy Market Estimates and Forecasts, 2017 to 2027 (USD Million)

Chapter 7 Anticoagulant Reversal Drugs Market: Regional Estimates & Trend Analysis

7.1 Regional Market Snapshot

7.2 Regional Market Share and Leading Players, 2020

7.2.1 North America

7.2.2 Europe

7.2.3 Latin America

7.2.4 Asia Pacific

7.2.5 Middle East & Africa

7.3 Market Share Analysis by Country, 2020

7.3.1 North America

7.3.1.1 U.S.

7.3.1.2 Canada

7.3.2 Europe

7.3.2.1 U.K.

7.3.2.2 Germany

7.3.2.3 Spain

7.3.2.4 France

7.3.2.5 Italy

7.3.2.6 Russia

7.3.3 Latin America

7.3.3.1 Brazil

7.3.3.2 Mexico

7.3.3.3 Argentina

7.3.4 Asia Pacific

7.3.4.1 Japan

7.3.4.2 China

7.3.4.3 India

7.3.4.4 South Korea

7.3.4.5 Singapore

7.3.4.6 Australia

7.3.5 Middle East & Africa

7.3.5.1 South Africa

7.3.5.2 Saudi Arabia

7.3.5.3 UAE

7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

7.4.1 North America

7.4.2 Europe

7.4.3 Latin America

7.4.4 Asia Pacific

7.4.5 Middle East & Africa

7.5 Market Size & Forecasts, and Trend Analysis, 2020 to 2027

7.5.1 North America

7.5.1.1 Market Size & Forecasts and Trend Analysis, 2017 to 2027 (USD Million)

7.5.1.2 U.S.

7.5.1.2.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.1.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.1.3 Canada

7.5.1.3.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.1.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.2 Europe

7.5.2.1 Market Size & Forecasts and Trend Analysis, 2017 to 2027 (USD Million)

7.5.2.2 U.K.

7.5.2.2.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.2.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.2.3 Germany

7.5.2.3.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.2.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.2.4 Spain

7.5.2.4.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.2.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.2.5 France

7.5.2.5.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.2.5.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.2.6 Italy

7.5.2.6.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.2.6.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.2.7 Russia

7.5.2.7.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.2.7.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.3 Latin America

7.5.3.1 Market Size & Forecasts and Trend Analysis, 2017 to 2027 (USD Million)

7.5.3.2 Brazil

7.5.3.2.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.3.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.3.3 Mexico

7.5.3.3.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.3.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.3.4 Argentina

7.5.3.4.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.3.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.4 Asia Pacific

7.5.4.1 Market Size & Forecasts and Trend Analysis, 2017 to 2027 (USD Million)

7.5.4.2 Japan

7.5.4.2.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.4.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.4.3 China

7.5.4.3.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.4.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.4.4 India

7.5.4.4.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.4.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.4.5 South Korea

7.5.4.5.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.4.5.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.4.6 Singapore

7.5.4.6.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.4.6.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.4.7 Australia

7.5.4.7.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.4.7.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.5 Middle East & Africa

7.5.5.1 Market Size & Forecasts and Trend Analysis, 2017 to 2027 (USD Million)

7.5.5.2 South Africa

7.5.5.2.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.5.2.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.5.3 Saudi Arabia

7.5.5.3.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.5.3.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

7.5.5.4 UAE

7.5.5.4.1 Market Size & Forecasts and Trend Analysis, By Product Type, 2017 to 2027 (USD Million)

7.5.5.4.2 Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2017 to 2027 (USD Million)

Chapter 8 Company Profiles

8.1 Company Profiles

8.1.1 Portola Pharmaceuticals

8.1.1.1 Company overview

8.1.1.2 Financial Performance

8.1.1.3 Product benchmarking

8.1.1.4 Strategic initiatives

8.1.2 Boehringer Ingelheim

8.1.2.1 Company overview

8.1.2.2 Financial Performance

8.1.2.3 Product benchmarking

8.1.2.4 Strategic initiatives

8.1.3 CSL Behring

8.1.3.1 Company overview

8.1.3.2 Financial Performance

8.1.3.3 Product benchmarking

8.1.3.4 Strategic initiatives

8.1.4 Bausch Health Companies Inc.

8.1.4.1 Company overview

8.1.4.2 Financial Performance

8.1.4.3 Product benchmarking

8.1.4.4 Strategic initiatives

8.1.5 Octapharma AG

8.1.5.1 Company overview

8.1.5.2 Financial Performance

8.1.5.3 Product benchmarking

8.1.5.4 Strategic initiatives

8.1.6 Dr. Reddy's Laboratories

8.1.6.1 Company overview

8.1.6.2 Financial Performance

8.1.6.3 Product benchmarking

8.1.6.4 Strategic initiatives

8.1.7 AMAG Pharmaceuticals, Inc.

8.1.7.1 Company overview

8.1.7.2 Financial Performance

8.1.7.3 Product benchmarking

8.1.7.4 Strategic initiatives

8.1.8 Pfizer, Inc.

8.1.8.1 Company overview

8.1.8.2 Financial Performance

8.1.8.3 Product benchmarking

8.1.8.4 Strategic initiatives

8.1.9 SG Pharma Pvt. Ltd.

8.1.9.1 Company overview

8.1.9.2 Financial Performance

8.1.9.3 Product benchmarking

8.1.9.4 Strategic initiatives

8.1.10 Alps Pharmaceutical Ind. Co., Ltd.

8.1.10.1 Company overview

8.1.10.2 Financial Performance

8.1.10.3 Product benchmarking

8.1.10.4 Strategic initiatives

8.1.11 Fresenius Kabi AG

8.1.11.1 Company overview

8.1.11.2 Financial Performance

8.1.11.3 Product benchmarking

8.1.11.4 Strategic initiatives

Choose License Type